Jasbir Seehra
2022
In 2022, Jasbir Seehra earned a total compensation of $6.5M as Chief Executive Officer and Director at Keros Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $60,500 |
|---|---|
| Non-Equity Incentive Plan | $302,500 |
| Option Awards | $5,475,349 |
| Salary | $610,817 |
| Other | $11,767 |
| Total | $6,460,934 |
Seehra received $5.5M in option awards, accounting for 85% of the total pay in 2022.
Seehra also received $60.5K in bonus, $302.5K in non-equity incentive plan, $610.8K in salary and $11.8K in other compensation.
Rankings
In 2022, Jasbir Seehra's compensation ranked 456th out of 5,760 executives tracked by ExecPay. In other words, Seehra earned more than 92.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 456 out of 5,760 | 92nd |
Division Manufacturing | 190 out of 3,136 | 94th |
Major group Chemicals And Allied Products | 51 out of 1,422 | 96th |
Industry group Drugs | 39 out of 1,323 | 97th |
Industry Pharmaceutical Preparations | 26 out of 969 | 97th |
Source: SEC filing on April 24, 2023.
Seehra's colleagues
We found two more compensation records of executives who worked with Jasbir Seehra at Keros Therapeutics in 2022.